Orthocell Ltd (ASX:OCC) is a regenerative medicine company focused on regenerating mobility for patients by developing products for the repair of a variety of soft tissue injuries.
Orthocell’s portfolio of products include CelGro®, a collagen medical device which facilitates tissue repair and healing.
The company is well-positioned to establish its CelGro® product as the best-in-class membrane for bone and soft tissue repair and to realise multiple commercial partnering opportunities.
